Oncology & Cancer

Denosumab reduces burden of giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according ...

Medical research

Engineering a better hip implant

University of Iowa researchers have determined that thigh size in obese people is a reason their hip implants are more likely to fail.

Medical research

hand held device reduces muscle pain in thirty minutes

Using a hand held device the size of a computer mouse for just 30 minutes could significantly change how people deal with, and recover from, the pain associated with musculoskeletal conditions.

Medications

FDA panel to weigh second chance for new class of painkillers

(HealthDay) -- A U.S. Food and Drug Administration advisory panel on Monday will weigh the wisdom of allowing new clinical trials of a class of powerful painkillers for osteoarthritis. The drugs may have worked so well for ...

Diseases, Conditions, Syndromes

Immunization for MRSA on the horizon

Methicillin resistant staph aureus (MRSA) infections are resistant to antibiotics and can cause a myriad of problems -- bone erosion, or osteomyelitis, which shorten the effective life of an implant and greatly hinder replacement ...

Health

Injured boomers beware: Know when to see doctor

(AP) -- It happened to nurse Jane Byron years after an in-line skating fall, business owner Haralee Weintraub while doing "men's" push-ups, and avid cyclist Gene Wilberg while lifting a heavy box.

page 13 from 21